Phosphorylated alpha-synuclein distribution in the colonic enteric nervous system of patients with diverticular disease

Phosphorylated alpha-synuclein distribution in the colonic enteric nervous system of patients with diverticular disease

Background: Phosphorylated alpha-synuclein (P-aSyn) is a biomarker for Parkinson’s disease (PD), with potential relevance in intestinal inflammatory disorders. Objectives: This study examines the distribution of P-aSyn in colonic tissues of patients with diverticular disease (DD) compared to age-mat...

Full description

Saved in:

Bibliographic Details
Main Authors:	François Cossais, Marie Christin Hörnke, Katja Schröder, Ralph Lucius, Martina Böttner, Jan-Hendrik Egberts, Florian Richter, Thilo Wedel
Format:	Article
Language:	English
Published:	Elsevier 2025-06-01
Series:	IBRO Neuroscience Reports
Subjects:	Enteric nervous system Alpha-synuclein Parkinson’s disease Diverticular disease Intestinal inflammation
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667242125000272
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Modifiable risk factors for the development and severe course of diverticular disease: a review
by: Natalia Niderla
Published: (2024-11-01)

STATE-OF-THE-ART: DIAGNOSIS AND TREATMENT FOR LARGE INTESTINE DIVERTICULAR DISEASE (APPROACHES AND TECHNIQUES REVIEW)
by: D. P. Puzanov, et al.
Published: (2019-02-01)

LONG-TERM RESULTS OF SURGICAL TREATMENT OF DIVERTICULAR DISEASE OF COLON
by: V. I. Pomazkin, et al.
Published: (2016-04-01)

Diverticular disease of the large intestine: current state of the problem
by: N. A. Lysov, et al.
Published: (2020-12-01)

Pregnancy and Healthy Childbirth in a 37 Year-Old Patient with Diverticular Disease
by: P. S. Andreev, et al.
Published: (2020-12-01)

Is bowel preparation necessary for early colonoscopy in patients with suspected colonic diverticular bleeding?: A multicenter retrospective study with propensity score matching analysis
by: Takahiro Gonai, et al.
Published: (2024-04-01)

Bowel movement alterations predict the severity of diverticular disease and the risk of acute diverticulitis: a prospective, international study
by: Antonio Tursi, et al.
Published: (2025-01-01)

A Contemporary Multifaceted Insight into the Association Between Diabetes Mellitus and Diverticular Disease: An Update About Geriatric Syndrome
by: Ridwan Hashi, et al.
Published: (2025-02-01)

Patients with symptomatic uncomplicated diverticular disease have high fecal bile acid concentrations
by: Tsumugi Jono, et al.
Published: (2025-07-01)

Cyclic rifaximin therapy effectively prevents the recurrence of symptoms after exacerbation of symptomatic uncomplicated diverticular disease: a retrospective study
by: Anna M. Pietrzak, et al.
Published: (2019-03-01)

Russian Non-Interventional Study of the Efficacy and Tolerability of Rifaximin-α Therapy in Patients with Uncomplicated Diverticular Disease under the Conditions of Outpatient Practice
by: O. S. Shifrin, et al.
Published: (2020-04-01)

Management of urethral diverticular stone with stricture: a case report
by: Yogesh Boddepalli, et al.
Published: (2025-02-01)

Considering the fragility index in reporting trials on diverticular disease
by: Andrew P. Zbar, et al.
Published: (2025-06-01)

Deciphering the gut microbiota’s role in diverticular disease: insights from a Mendelian randomization study
by: Biaohui Zheng, et al.
Published: (2024-12-01)

Nueva clasificación endoscópica y factores de riesgo asociados a la enfermedad diverticular del colon
by: Misdrialis Martinez Romero, et al.
Published: (2024-05-01)

Trends and Changes in Endoscopic Management and Clinical Outcomes of Colonic Diverticular Bleeding during the Coronavirus Disease-2019 Pandemic
by: Takumi Komatsu, et al.
Published: (2024-10-01)

Serine-129 phosphorylated α-synuclein drives mitochondrial dysfunction and calcium dysregulation in Parkinson’s disease model
by: Jie Jiao, et al.
Published: (2025-03-01)

Bridging the gap: investigating the role of phosphorylation at the serine 129 site of α-synuclein in VAPB-PTPIP51 interactions
by: Weijin Liu, et al.
Published: (2025-02-01)

Does Parkinson's disease start in the gut?
by: Oscar S. Gershanik

A study of the quality of life in patients with diverticular colon disease, after suffering attacks of diverticulitis
by: A. L. Levchuk, et al.
Published: (2025-06-01)

Perfusion Computed Tomography in the Diagnosis of Colonic Diverticular Disease and its Complications
by: M. V. Timerbulatov, et al.
Published: (2023-10-01)

Interactions of alpha-synuclein with membranes in Parkinson's disease: Mechanisms and therapeutic strategies
by: Baoyi Li, et al.
Published: (2024-10-01)

Characteristics of the microbiome in patients with symptomatic uncomplicated colonic diverticular disease in the central region of Ukraine
by: A. E. Dorofieiev, et al.
Published: (2023-07-01)

Erythrocytic α-Synuclein in Parkinson’s Disease and Progressive Supranuclear Palsy—A Pilot Study
by: Costanza Maria Cristiani, et al.
Published: (2024-11-01)

Alpha-Synuclein Dysregulation in Systemic Pathophysiology of Synucleinopathies
by: Hallie H. Dolin, et al.
Published: (2025-07-01)

α-synuclein fibrils per se but not α-synuclein seeded aggregation causes mitochondrial dysfunction and cell death in human neurons
by: Plamena R. Angelova, et al.
Published: (2025-10-01)

Micro-encapsulated and colonic-release sodium butyrate modulates gut microbiota and improves abdominal pain in patients with symptomatic uncomplicated diverticular disease
by: Antonio Tursi, et al.
Published: (2025-02-01)

The interplay of iron, oxidative stress, and α-synuclein in Parkinson’s disease progression
by: Yan Chen, et al.
Published: (2025-04-01)

Alpha-synuclein inclusions reduced by PIKfyve inhibition in Parkinson disease cell models
by: Sara Lucas-Del-Pozo, et al.
Published: (2025-10-01)

Synthesis and preliminary biological evaluation of a novel PET tracer for α-synuclein PET imaging
by: WANG Ce, et al.
Published: (2024-10-01)

α‐Synuclein Pathology Spreads in a Midbrain–Hindbrain Assembloid Model
by: Gemma Gomez‐Giro, et al.
Published: (2025-05-01)

Diverticular bleeding in the third part of the duodenum as a cause of overt obscure gastrointestinal bleeding
by: Yasuhiko Hamada, et al.
Published: (2024-11-01)

Effect of hydrogen sulfide on alpha-synuclein aggregation and cell viability
by: Elena A. Ostrakhovitch, et al.
Published: (2025-05-01)

Tet2 loss and enhanced ciliogenesis suppress α-synuclein pathology
by: Emmanuel Quansah, et al.
Published: (2025-04-01)

c-Abl Inhibitors in Parkinson’s: Exploring Hypotheses on Alpha-Synuclein Modulation
by: Jyutia Nargish, et al.
Published: (2025-04-01)

THE LEVEL OF Α-SYNUCLEIN IN THE PLASMA AS A BIOMARKER OF PAIN IN PARKINSON'S DISEASE TAKING INTO ACCOUNT THE MOTOR SUBTYPES
by: K.A. Tarianyk
Published: (2024-07-01)

Parkinson’s Disease: A Narrative of the Evolving Understanding of the Role of α-Synuclein in Screening
by: Alan D. Kaye, et al.
Published: (2024-11-01)

α-Synuclein ubiquitination – functions in proteostasis and development of Lewy bodies
by: Hung-Hsiang Ho, et al.
Published: (2024-11-01)

β-synuclein in cerebrospinal fluid as a potential biomarker for distinguishing human prion diseases from Alzheimer’s and Parkinson’s disease
by: Bing Xu, et al.
Published: (2025-02-01)

Refining α-synuclein seed amplification assays to distinguish Parkinson’s disease from multiple system atrophy
by: James A. Wiseman, et al.
Published: (2025-02-01)